Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 144 of 144 entries
Sorted by: Best Match Show Resources per page
Munchausen.

Journal of the Royal Society of Medicine

Golden RL.
PMID: 20894822
J R Soc Med. 1992 Feb;85(2):120.

No abstract available.

Cite
Golden RL. Munchausen. J R Soc Med. 1992;85(2):120
Golden, R. L. (1992). Munchausen. Journal of the Royal Society of Medicine, 85(2), 120.
Golden, R L. "Munchausen." Journal of the Royal Society of Medicine vol. 85,2 (1992): 120.
Golden RL. Munchausen. J R Soc Med. 1992 Feb;85(2):120. PMID: 20894822; PMCID: PMC1294905.
Copy Download .nbib Format: NLM
William Osler's medical ethics in the 21st century.

Indian journal of medical ethics

Golden RL.
PMID: 22319859
Indian J Med Ethics. 2012 Jan-Mar;9(1):62-3. doi: 10.20529/IJME.2012.016.

No abstract available.

Cite
Golden RL. William Osler's medical ethics in the 21st century. Indian J Med Ethics. 2012;9(1):62-3doi: 10.20529/IJME.2012.016.
Golden, R. L. (2012). William Osler's medical ethics in the 21st century. Indian journal of medical ethics, 9(1), 62-3. https://doi.org/10.20529/IJME.2012.016
Golden, Richard L. "William Osler's medical ethics in the 21st century." Indian journal of medical ethics vol. 9,1 (2012): 62-3. doi: https://doi.org/10.20529/IJME.2012.016
Golden RL. William Osler's medical ethics in the 21st century. Indian J Med Ethics. 2012 Jan-Mar;9(1):62-3. doi: 10.20529/IJME.2012.016. PMID: 22319859.
Copy Download .nbib Format: NLM
Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data.

The open AIDS journal

Buskin SE, Fida NG, Bennett AB, Golden MR, Stekler JD.
PMID: 25317222
Open AIDS J. 2014 Sep 30;8:45-9. doi: 10.2174/1874613601408010045. eCollection 2014.

BACKGROUND: The U.S. HIV staging system is being revised to more comprehensively track early and acute HIV infection (AHI). We evaluated our ability to identify known cases of AHI using King County (KC) HIV surveillance data.METHODOLOGY: AHI cases were...

Cite
Buskin SE, Fida NG, Bennett AB, et al. Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data. Open AIDS J. 2014;8:45-9doi: 10.2174/1874613601408010045.
Buskin, S. E., Fida, N. G., Bennett, A. B., Golden, M. R., & Stekler, J. D. (2014). Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data. The open AIDS journal, 845-9. https://doi.org/10.2174/1874613601408010045
Buskin, Susan E, et al. "Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data." The open AIDS journal vol. 8 (2014): 45-9. doi: https://doi.org/10.2174/1874613601408010045
Buskin SE, Fida NG, Bennett AB, Golden MR, Stekler JD. Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data. Open AIDS J. 2014 Sep 30;8:45-9. doi: 10.2174/1874613601408010045. eCollection 2014. PMID: 25317222; PMCID: PMC4192836.
Copy Download .nbib Format: NLM
Identifying pathophysiological bases of disease in COVID-19.

Translational medicine communications

Goldin CJ, Vázquez R, Polack FP, Alvarez-Paggi D.
PMID: 32984543
Transl Med Commun. 2020;5(1):15. doi: 10.1186/s41231-020-00067-w. Epub 2020 Sep 22.

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that can affect lung physiology encompassing a wide spectrum of severities, ranging from asymptomatic and mild symptoms to severe and fatal cases; the latter including massive neutrophil infiltration, stroke...

Cite
Goldin CJ, Vázquez R, Polack FP, et al. Identifying pathophysiological bases of disease in COVID-19. Transl Med Commun. 2020;5(1):15doi: 10.1186/s41231-020-00067-w.
Goldin, C. J., Vázquez, R., Polack, F. P., & Alvarez-Paggi, D. (2020). Identifying pathophysiological bases of disease in COVID-19. Translational medicine communications, 5(1), 15. https://doi.org/10.1186/s41231-020-00067-w
Goldin, Carla J, et al. "Identifying pathophysiological bases of disease in COVID-19." Translational medicine communications vol. 5,1 (2020): 15. doi: https://doi.org/10.1186/s41231-020-00067-w
Goldin CJ, Vázquez R, Polack FP, Alvarez-Paggi D. Identifying pathophysiological bases of disease in COVID-19. Transl Med Commun. 2020;5(1):15. doi: 10.1186/s41231-020-00067-w. Epub 2020 Sep 22. PMID: 32984543; PMCID: PMC7506209.
Copy Download .nbib Format: NLM
Pediatric Gastrostomy Tube Placement: Lessons Learned from High-performing Institutions through Structured Interviews.

Pediatric quality & safety

Berman L, Hronek C, Raval MV, Browne ML, Snyder CL, Heiss KF, Rangel SJ, Goldin AB, Rothstein DH.
PMID: 30229155
Pediatr Qual Saf. 2017 Feb 23;2(2):e016. doi: 10.1097/pq9.0000000000000016. eCollection 2017.

INTRODUCTION: Gastrostomy tube (GT) placement is one of the most common operations performed in children, and it is plagued by high complication rates. Previous studies have shown variation in readmission and emergency room visit rates across different children's hospitals,...

Cite
Berman L, Hronek C, Raval MV, et al. Pediatric Gastrostomy Tube Placement: Lessons Learned from High-performing Institutions through Structured Interviews. Pediatr Qual Saf. 2017;2(2):e016doi: 10.1097/pq9.0000000000000016.
Berman, L., Hronek, C., Raval, M. V., Browne, M. L., Snyder, C. L., Heiss, K. F., Rangel, S. J., Goldin, A. B., & Rothstein, D. H. (2017). Pediatric Gastrostomy Tube Placement: Lessons Learned from High-performing Institutions through Structured Interviews. Pediatric quality & safety, 2(2), e016. https://doi.org/10.1097/pq9.0000000000000016
Berman, Loren, et al. "Pediatric Gastrostomy Tube Placement: Lessons Learned from High-performing Institutions through Structured Interviews." Pediatric quality & safety vol. 2,2 (2017): e016. doi: https://doi.org/10.1097/pq9.0000000000000016
Berman L, Hronek C, Raval MV, Browne ML, Snyder CL, Heiss KF, Rangel SJ, Goldin AB, Rothstein DH. Pediatric Gastrostomy Tube Placement: Lessons Learned from High-performing Institutions through Structured Interviews. Pediatr Qual Saf. 2017 Feb 23;2(2):e016. doi: 10.1097/pq9.0000000000000016. eCollection 2017. PMID: 30229155; PMCID: PMC6132912.
Copy Download .nbib Format: NLM
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.

Endocrine connections

Clift AK, Faiz O, Goldin R, Martin J, Wasan H, Liedke MO, Schloericke E, Malczewska A, Rindi G, Kidd M, Modlin IM, Frilling A.
PMID: 28104724
Endocr Connect. 2017 Feb;6(2):71-81. doi: 10.1530/EC-16-0114. Epub 2017 Jan 19.

Neuroendocrine tumours (NET) are clinically challenging due to their unpredictable behaviour. Nomograms, grading and staging systems are predictive tools with multiple roles in clinical practice, including patient prognostication. The NET nomogram allocates scores for various clinicopathological parameters, calculating percentage...

Cite
Clift AK, Faiz O, Goldin R, et al. Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems. Endocr Connect. 2017;6(2):71-81doi: 10.1530/EC-16-0114.
Clift, A. K., Faiz, O., Goldin, R., Martin, J., Wasan, H., Liedke, M. O., Schloericke, E., Malczewska, A., Rindi, G., Kidd, M., Modlin, I. M., & Frilling, A. (2017). Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems. Endocrine connections, 6(2), 71-81. https://doi.org/10.1530/EC-16-0114
Clift, Ashley K, et al. "Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems." Endocrine connections vol. 6,2 (2017): 71-81. doi: https://doi.org/10.1530/EC-16-0114
Clift AK, Faiz O, Goldin R, Martin J, Wasan H, Liedke MO, Schloericke E, Malczewska A, Rindi G, Kidd M, Modlin IM, Frilling A. Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems. Endocr Connect. 2017 Feb;6(2):71-81. doi: 10.1530/EC-16-0114. Epub 2017 Jan 19. PMID: 28104724; PMCID: PMC5424775.
Copy Download .nbib Format: NLM
Current Approach to the Management of Eosinophilic Esophagitis in Adults.

Current treatment options in gastroenterology

Goldin AH, Chan WW.
PMID: 26454851
Curr Treat Options Gastroenterol. 2015 Dec;13(4):441-51. doi: 10.1007/s11938-015-0069-4.

OPINION STATEMENT: Eosinophilic esophagitis (EoE) is an increasingly diagnosed, immune-mediated disease characterized by inflammation of the esophagus in both children and adult, causing significant morbidity. Adults typically present with dysphagia and a history of food impaction. Diagnosis should be...

Cite
Goldin AH, Chan WW. Current Approach to the Management of Eosinophilic Esophagitis in Adults. Curr Treat Options Gastroenterol. 2015;13(4):441-51doi: 10.1007/s11938-015-0069-4.
Goldin, A. H., & Chan, W. W. (2015). Current Approach to the Management of Eosinophilic Esophagitis in Adults. Current treatment options in gastroenterology, 13(4), 441-51. https://doi.org/10.1007/s11938-015-0069-4
Goldin, Alison H, and Chan, Walter W. "Current Approach to the Management of Eosinophilic Esophagitis in Adults." Current treatment options in gastroenterology vol. 13,4 (2015): 441-51. doi: https://doi.org/10.1007/s11938-015-0069-4
Goldin AH, Chan WW. Current Approach to the Management of Eosinophilic Esophagitis in Adults. Curr Treat Options Gastroenterol. 2015 Dec;13(4):441-51. doi: 10.1007/s11938-015-0069-4. PMID: 26454851.
Copy Download .nbib Format: NLM
Improved pathology reporting in NAFLD/NASH for clinical trials.

Journal of clinical pathology

Langford CR, Goldinger MH, Treanor D, McGenity C, Dillman JR, Allende DS, Goldin R, Brunt EM, Zatloukal K, Denk H, Fleming KA.
PMID: 34753791
J Clin Pathol. 2021 Nov 09; doi: 10.1136/jclinpath-2021-207967. Epub 2021 Nov 09.

No abstract available.

Cite
Langford CR, Goldinger MH, Treanor D, et al. Improved pathology reporting in NAFLD/NASH for clinical trials. J Clin Pathol. 2021;doi: 10.1136/jclinpath-2021-207967.
Langford, C. R., Goldinger, M. H., Treanor, D., McGenity, C., Dillman, J. R., Allende, D. S., Goldin, R., Brunt, E. M., Zatloukal, K., Denk, H., & Fleming, K. A. (2021). Improved pathology reporting in NAFLD/NASH for clinical trials. Journal of clinical pathology, . https://doi.org/10.1136/jclinpath-2021-207967
Langford, Caitlin Rose, et al. "Improved pathology reporting in NAFLD/NASH for clinical trials." Journal of clinical pathology vol. (2021). doi: https://doi.org/10.1136/jclinpath-2021-207967
Langford CR, Goldinger MH, Treanor D, McGenity C, Dillman JR, Allende DS, Goldin R, Brunt EM, Zatloukal K, Denk H, Fleming KA. Improved pathology reporting in NAFLD/NASH for clinical trials. J Clin Pathol. 2021 Nov 09; doi: 10.1136/jclinpath-2021-207967. Epub 2021 Nov 09. PMID: 34753791.
Copy Download .nbib Format: NLM
Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Khosropour CM, Soge OO, Golden MR, Hughes JP, Barbee LA.
PMID: 34893806
Clin Infect Dis. 2021 Dec 10; doi: 10.1093/cid/ciab1022. Epub 2021 Dec 10.

BACKGROUND: The prevalence of pharyngeal chlamydia is low but its incidence and duration are unknown. A high incidence or duration may support the role of pharyngeal chlamydia in sustaining chlamydia transmission.METHODS: From March 2016 to December 2018 we enrolled...

Cite
Khosropour CM, Soge OO, Golden MR, et al. Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab1022.
Khosropour, C. M., Soge, O. O., Golden, M. R., Hughes, J. P., & Barbee, L. A. (2021). Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab1022
Khosropour, Christine M, et al. "Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab1022
Khosropour CM, Soge OO, Golden MR, Hughes JP, Barbee LA. Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men. Clin Infect Dis. 2021 Dec 10; doi: 10.1093/cid/ciab1022. Epub 2021 Dec 10. PMID: 34893806.
Copy Download .nbib Format: NLM
Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Goldin L, Elders T, Werhane L, Korwek K, Poland R, Guy J.
PMID: 34508863
Int J Infect Dis. 2021 Nov;112:73-75. doi: 10.1016/j.ijid.2021.09.007. Epub 2021 Sep 08.

SARS-CoV-2 monoclonal antibodies (mAbs) have been proposed as a treatment for mild to moderate COVID-19, with favorable outcomes reported in clinical trials and an emergency use authorization granted by the Food and Drug Administration. Real-world data remain limited, however,...

Cite
Goldin L, Elders T, Werhane L, et al. Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion. Int J Infect Dis. 2021;112:73-75doi: 10.1016/j.ijid.2021.09.007.
Goldin, L., Elders, T., Werhane, L., Korwek, K., Poland, R., & Guy, J. (2021). Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11273-75. https://doi.org/10.1016/j.ijid.2021.09.007
Goldin, Laurel, et al. "Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 112 (2021): 73-75. doi: https://doi.org/10.1016/j.ijid.2021.09.007
Goldin L, Elders T, Werhane L, Korwek K, Poland R, Guy J. Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion. Int J Infect Dis. 2021 Nov;112:73-75. doi: 10.1016/j.ijid.2021.09.007. Epub 2021 Sep 08. PMID: 34508863; PMCID: PMC8425746.
Copy Download .nbib Format: NLM
A framework for evaluating island restoration performance: A case study from the Chesapeake Bay.

Integrated environmental assessment and management

Davis J, Whitfield P, Szimanski D, Golden BR, Whitbeck M, Gailani J, Herman B, Tritinger A, Dillon SC, King J.
PMID: 33913621
Integr Environ Assess Manag. 2021 Apr 29; doi: 10.1002/ieam.4437. Epub 2021 Apr 29.

The use of natural habitats for coastal protection (also known as Nature-Based Solutions or NBS) in place of engineered structures like breakwaters and seawalls can yield a wide range of ecological and economic benefits. Despite these advantages, NBS are...

Cite
Davis J, Whitfield P, Szimanski D, et al. A framework for evaluating island restoration performance: A case study from the Chesapeake Bay. Integr Environ Assess Manag. 2021;doi: 10.1002/ieam.4437.
Davis, J., Whitfield, P., Szimanski, D., Golden, B. R., Whitbeck, M., Gailani, J., Herman, B., Tritinger, A., Dillon, S. C., & King, J. (2021). A framework for evaluating island restoration performance: A case study from the Chesapeake Bay. Integrated environmental assessment and management, . https://doi.org/10.1002/ieam.4437
Davis, Jenny, et al. "A framework for evaluating island restoration performance: A case study from the Chesapeake Bay." Integrated environmental assessment and management vol. (2021). doi: https://doi.org/10.1002/ieam.4437
Davis J, Whitfield P, Szimanski D, Golden BR, Whitbeck M, Gailani J, Herman B, Tritinger A, Dillon SC, King J. A framework for evaluating island restoration performance: A case study from the Chesapeake Bay. Integr Environ Assess Manag. 2021 Apr 29; doi: 10.1002/ieam.4437. Epub 2021 Apr 29. PMID: 33913621.
Copy Download .nbib Format: NLM
Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification using Rapid Evaporative Ionisation Mass Spectrometry.

Annals of surgery

Mason SE, Manoli E, Alexander JL, Poynter L, Ford L, Paizs P, Adebesin A, McKenzie JS, Rosini F, Goldin R, Darzi A, Takats Z, Kinross JM.
PMID: 34387206
Ann Surg. 2021 Aug 13; doi: 10.1097/SLA.0000000000005164. Epub 2021 Aug 13.

OBJECTIVE: Rapid Evaporative Ionisation Mass Spectrometry (REIMS) is a metabolomic technique analysing tissue metabolites, which can be applied intra-operatively in real-time. The objective of this study was to profile the lipid composition of colorectal tissues using REIMS, assessing its...

Cite
Mason SE, Manoli E, Alexander JL, et al. Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification using Rapid Evaporative Ionisation Mass Spectrometry. Ann Surg. 2021;doi: 10.1097/SLA.0000000000005164.
Mason, S. E., Manoli, E., Alexander, J. L., Poynter, L., Ford, L., Paizs, P., Adebesin, A., McKenzie, J. S., Rosini, F., Goldin, R., Darzi, A., Takats, Z., & Kinross, J. M. (2021). Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification using Rapid Evaporative Ionisation Mass Spectrometry. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000005164
Mason, Sam E, et al. "Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification using Rapid Evaporative Ionisation Mass Spectrometry." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000005164
Mason SE, Manoli E, Alexander JL, Poynter L, Ford L, Paizs P, Adebesin A, McKenzie JS, Rosini F, Goldin R, Darzi A, Takats Z, Kinross JM. Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification using Rapid Evaporative Ionisation Mass Spectrometry. Ann Surg. 2021 Aug 13; doi: 10.1097/SLA.0000000000005164. Epub 2021 Aug 13. PMID: 34387206.
Copy Download .nbib Format: NLM
Showing 133 to 144 of 144 entries